CEP68

Across TCGA pan-cancer cohorts, CEP68 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CEP68’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CEP68 RNA is repressed in tumor relative to normal tissue. In most cancer types CEP68 is over-expressed in tumor, although a few such as THCA and BLCA show the opposite, repressed pattern.

THCA, LIHC, and BLCA are the cancer types where CEP68 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEP68 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−1.009	<.001	10	view →
LIHC	Male	II,III,IV	+1.124	<.001	9	view →
BLCA	Male	IV	−1.700	.005	8	view →
KICH	Female	All	−1.410	<.001	8	view →
UCEC	All	All	−1.180	<.001	6	view →
BRCA	Female	All	−1.005	<.001	6	view →
CHOL	Female	All	+2.656	<.001	5	view →
STAD	Female	All	−0.768	.031	2	view →
KIRP	Male	All	−0.560	<.001	2	view →
LUAD	Female	II,III,IV	−0.526	.002	2	view →
LUSC	Female	All	+0.480	.014	2	view →
PRAD	All	All	−0.479	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CEP68–THCA

Open the THCA breakdown →